BioSpace News Archive

Drug Development

Spring Bank Pharmaceuticals Announces Positive Top-Line Results from the Second Cohort of Part A of the Phase II ACHIEVE Trial

All patients in this cohort have transitioned to tenofovir disoproxil fumarate300mg daily for an additional 12 weeks.

November 16, 2017

·

10 min read

Drug Development

Titan Medical Reports First Use of Sport Surgical System at Columbia University Medical Center

The demonstration is the first step of the preclinical feasibility and validation studies with the SPORT system completed at this world-renowned academic medical center, one of Titan’s two Centers of Excellence in the U.S.

November 16, 2017

·

6 min read

BioMidwest

IDT Provides Optimized Conditions for HDR in CRISPR Editing

Available as part of the IDT collection of CRISPR application notes and protocols, this article supports researchers using CRISPR in their genome editing studies to maximize HDR rate in knock-in and other short-insertion experiments.

November 16, 2017

·

1 min read

Leaders in Technology and Drug Development Collaborate at CNS Summit 2017 to Shape the Future of Clinical Development

Leaders in technology and drug development are meeting at CNS Summit 2017 to collaborate on initiatives and programs to shape the future of clinical development.

November 16, 2017

·

1 min read

InDex Pharma Announces Nomination Committee and Financial Reporting Dates for 2018

InDex Pharma today announced the composition of the Nomination Committee for the 2018 Annual General Meeting, which will be held on Thursday May 24, 2018.

November 16, 2017

·

2 min read

Deals

Arcturus Therapeutics Announces Completion of Merger With Alcobra and Commences Trading on the Nasdaq Global Market

The combined company has net cash of approximately $50.1 million, following the merger.

November 16, 2017

·

6 min read

Pharm Country

MTPA Announces 1,000 People With ALS Have Received FDA-Approved Treatment Option in First Three Months Available

MTPA today announced that more than 1,000 people with ALS have been treated with RADICAVA (edaravone) since it became available in the U.S. in August as the first FDA-approved treatment option for the disease in more than 20 years.

November 16, 2017

·

7 min read

Business

MacroGenics Names Dr. Jay Siegel to its Board of Directors

Dr. Siegel recently retired from Johnson & Johnson, which he joined in 2003.

November 16, 2017

·

4 min read

Drug Development

BioCanCell Announces Updated Results from the Phase II Clinical Trial of BC-819 and BCG in Patients With Bladder Cancer

Patients are being followed for up to 2 years, and the median follow-up at the time of the analysis is approximately 18 months.

November 16, 2017

·

5 min read

Tigenix Announces Approval of Trade Name for Lead Development Candidate Cx601 in Europe

The trade name Alofisel, a registered trademark owned by TiGenix, will be used from now onwards.

November 16, 2017

·

5 min read